Acrivon Therapeutics, Inc. Common Stock Profile Avatar - Palmy Investing

Acrivon Therapeutics, Inc. Common Stock

Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder ide…

Biotechnology
US, Watertown [HQ]
Supply · Problems · Premarket · Compliance

Supply Analysis

End of ACRV's Analysis
CIK: 1781174 CUSIP: 004890109 ISIN: US0048901096 LEI: - UEI: -
Secondary Listings
ACRV has no secondary listings inside our databases.